SCHEMBL31716148

SCHEMBL31716148

CC(C)(C)OC(=O)Cc1csc(-c2ccccn2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KB2 Q9UBS0 2/20 0.46
▸ NR1H2 P55055 1/20 0.42
▸ BAZ2B Q9UIF8 2/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ BRD2 P25440 1/20 0.39
▸ BRD3 Q15059 1/20 0.39
▸ BAZ2A Q9UIF9 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ HDAC3 O15379 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716338 0.80 RPS6KB2 (0.57) RPS6KB2KDM4EHDAC3HDAC4HDAC1
SCHEMBL27613084 0.72 KDM4E (0.40) RPS6KB2KDM4EHDAC3HDAC4HDAC1
SCHEMBL23011276 0.71 LMNA (0.42) NR1H2KDM4EALDH1A1APOBEC3GSMN1; SMN2
SCHEMBL29676749 0.71 ALDH1A1 (0.51) KDM4ERAB9ANPC1MAPTALDH1A1
SCHEMBL6339719 0.71 ALDH1A1 (0.51) KDM4ERAB9ANPC1MAPTALDH1A1
SCHEMBL27520004 0.69 TSHR (0.53) ALDH1A1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL1346095 0.69 TSHR (0.56) ALDH1A1SMN1; SMN2MTNR1AMTNR1B
SCHEMBL27612819 0.69 KDM4E (0.42) BAZ2BBRD4BRD2BRD3BAZ2A
SCHEMBL18430442 0.69 KDM4E (0.48) KDM4EHDAC3HDAC4HDAC1HDAC7
SCHEMBL27605065 0.68 KDM4E (0.49) BAZ2BBRD4BRD2BRD3BAZ2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback